Skip to content
zameds

Cloxacillin (Cloxin, Megamox, Megamox S)

Cloxacillin

Pharmacare limited û woodmead

Registration

Applicant
Pharmacare limited û woodmead
Registrations
4

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Cloxin 250 MG capsules

EACH CAPSULE CONTAINS CLOXACILLIN SODIUM EQUIVALENT TO 250 mg CLOXACILLIN

250 mgCapsulesN0090N/20.1.2/90RegisteredNot determinedNone
Cloxin 500 MG capsules

EACH CAPSULE CONTAINS CLOXACILLIN SODIUM EQUIVALENT TO 500 mg CLOXACILLIN

500 mgCapsulesN0091N/20.1.2/91RegisteredNot determinedNone
Megamox 500 MG

EACH CAPSULE CONTAINS AMPICILLIN TRIHYDRATE EQUIVALENT TO AMPICILLIN 250 mg CLOXACILLIN SODIUM EQUIVALENT TO CLOXACILLIN 250 mg

500 mgZ0355Z/20.1.2/355CancelledNot determinedNone
Megamox s

EACH 5 ml SYRUP CONTAINS AMPICILLIN TRIHYDRATE EQUIVALENT TO AMPICILLIN 125 mg CLOXACILLIN SODIUM EQUIVALENT TO CLOXACILLIN 125 mg

Not listedZ0356Z/20.1.2/356CancelledNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S4: Ampicillin

    • except when listed elsewhere in the Schedules and except intra-mammary preparations thereof, containing tracer dye(s) and intended for the treatment of mastitis in cattle and registered in terms of the provisions of the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947. (Act 36 of 1947)

    Consolidated Schedules 06 July 2026, lines 5240 to 5242

  • S4: Cloxacillin

    • except when listed elsewhere in the Schedules and except intra-mammary preparations thereof, containing tracer dye(s) and intended for the treatment of mastitis in cattle and registered in terms of the provisions of the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act 36 of 1947).

    Consolidated Schedules 06 July 2026, lines 5862 to 5864

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C19H18ClN3O5S435.90 g/mol

(2S,5R,6R)-6-[[3-(2-Chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

Drag to rotate. Structure from PubChem CID 6098.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles